drugset / Trial / NCT00689416

Effects of Crestor on Inflammation of Atherosclerotic Plaques

NCT00689416

Phase 0 Completed 74 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The primary aim of this study is to investigate the effect of 40 mg dose of rosuvastatin on carotid plaque inflammation measured with MRI and PET scanning, to evaluate whether these techniques are promising for future proof of principle studies. A number of patients will receive placebo as a control.

Timeline

Start
2007-12
Primary completion
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 40 mg

Indications